Zoetis Declares First Quarter 2018 Dividend; Board Approves 20% Payment Increase
December 11 2017 - 04:22PM
Business Wire
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a
first quarter 2018 dividend payable to holders of the company’s
common stock of $0.126 per share, an increase of 20% from the
quarterly dividend rate paid in 2017. The dividend is to be paid on
Thursday, March 1, 2018, to holders of record on Friday, January
19, 2018.
“In 2017, Zoetis has continued to deliver steady, profitable
growth based on our diverse portfolio, improved cost structure and
ongoing investments in innovation,” said Juan Ramón Alaix, Chief
Executive Officer of Zoetis. “We have been able to improve our cash
flow generation based on this performance, and with the Board’s
approval, I am pleased to announce that we are once again
increasing our dividend - by 20% in 2018 - as part of our
commitment to returning excess capital to shareholders.”
About Zoetis
Zoetis is the leading animal health company, dedicated to
supporting its customers and their businesses. Building on more
than 60 years of experience in animal health, Zoetis discovers,
develops, manufactures and markets veterinary vaccines and
medicines, complemented by diagnostic products, genetic tests,
biodevices and a range of services. Zoetis serves veterinarians,
livestock producers and people who raise and care for farm and
companion animals with sales of its products in more than 100
countries. In 2016, the company generated annual revenue of $4.9
billion with approximately 9,000 employees. For more information,
visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-Looking
Statements: This press release contains forward-looking
statements, which reflect the current views of Zoetis with respect
to business plans or prospects, future operating or financial
performance, future use of cash and dividend payments, and
other future events. These statements are not guarantees of future
performance or actions. Forward-looking statements are subject to
risks and uncertainties. If one or more of these risks or
uncertainties materialize, or if management's underlying
assumptions prove to be incorrect, actual results may differ
materially from those contemplated by a forward-looking statement.
Forward-looking statements speak only as of the date on which they
are made. Zoetis expressly disclaims any obligation to update or
revise any forward-looking statement, whether as a result of new
information, future events or otherwise. A further list and
description of risks, uncertainties and other matters can be found
in our Annual Report on Form 10-K for the fiscal year ended
December 31, 2016, including in the sections thereof captioned
“Forward-Looking Statements and Factors That May Affect Future
Results” and “Item 1A. Risk Factors,” in our Quarterly Reports on
Form 10-Q and in our Current Reports on Form 8-K. These filings and
subsequent filings are available online at www.sec.gov,
www.zoetis.com, or on request from Zoetis.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171211006211/en/
Zoetis Inc.Media:Elinore White, 1-973-443-2835
(o)elinore.y.white@zoetis.comorKristen Seely, 1-973-443-2777
(o)kristen.seely@zoetis.comorInvestors:Steve Frank,
1-973-822-7141 (o)steve.frank@zoetis.com
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Feb 2024 to Mar 2024
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Mar 2023 to Mar 2024